Activity Stream
@moatrx
• 2 weeks ago
Posted a new blog:
US FABRY DISEASE LAUNCH READINESS
US FABRY DISEASE LAUNCH READINESS
Only 200 to 400 US Fabry patients define the ADA-positive niche left open by agalsidase failure, with one competitor and one testing bottleneck.
Agalsidase beta...



